News & Analysis on Clinical Trial Services & Contract Research And Development
GS1, the global not-profit organisation, that designs and implements barcode standards, has announced a global adoption date of 1 January 2010 for a new bar code with Reduced Space Symbology (RSS), which can store more data in half the amount of space...
Genevac have developed a Fast Lyophilisation Process that aims to provide the ultimate solution to the problems encountered by lab technicians when handling HPLC solvents.
Inspection and certification group SGS has officially launched a laboratory in Shanghai dedicated to quality control testing of pharmaceuticals, biopharmaceuticals and medical devices, as China's appetite for contract analytical services increases.
The PiperJaffray conference gave biopharmaceutical company Speedel ample opportunity to inform investors of its intentions for 2006 and beyond. The company have just released promising data on a new first-in-class diabetic treatment.
UK biopharma firm Adjuvantix has developed a new technology that it claims can increase the effectiveness of vaccines as well as drugs for cancer, inflammatory diseases and infectious diseases such as tuberculosis and AIDS.
Covalent Group has won several new clinical trial contracts to the tune of $2.1m (€1.7m) and said it expects the windfall to help it return to profitability for the second quarter.
Dynal has announced today the release of a new research tool in its immunotherapy range that allow researchers to isolate and collect T cells from immunocompromised patients for ex vivo stimulation and expansion in a sterile environment.
PRA International has been busy implementing an advanced data management system as part of a number of new internal measures aimed at improving operating efficiency and cutting the costs of clinical trials.
In an incident that state and federal environmental regulators are treating as "serious," Merck released 25 gallons of a cyanide-containing chemical from its West Point facility in Pennsylvania to the sewer, killing hundreds of fish and triggering...
Tate and Lyle has announced the launch of Meritab - a new direct compressible dextrose - that allows pharma tablet manufacturers to stop using wet granulation processes, and so offers a cost effective and simplified production process.